Moderna: FDA delaying decision on its shot for adolescents
U.S. regulators are delaying their decision on Moderna’s COVID-19 vaccine for 12- to 17-year-olds while they study the rare risk of heart inflammation, the company said Sunday.
U.S. regulators are delaying their decision on Moderna’s COVID-19 vaccine for 12- to 17-year-olds while they study the rare risk of heart inflammation, the company said Sunday.
In Indiana last year, dozens of insurers across the state rolled out plans hoping to get a sizable piece of the fast-growing market.
The results seem to show that the pandemic is continuing to push hospitals to the limit, as patients flock to emergency rooms and surgical suites for care.
Breakthrough cases of COVID-19—when a fully vaccinated person tests positive for the virus—make up a low ratio of COVID cases in Indiana, but they aren’t extremely rare.
Indiana officials said Wednesday that the state should be able to immediately inoculate a third of children ages 5 to 11 if the federal government gives approval to vaccines for that age group.
Researchers tested the pill used for depression and obsessive-compulsive disorder because it was known to reduce inflammation and looked promising in smaller studies.
The cumulative total of deaths during the pandemic officially rose to 16,022, the department said Tuesday. Another 545 probable deaths due to COVID also have been reported.
A federal judge in Indianapolis has tossed out Community Health Network’s motion to dismiss a lawsuit by the U.S. Justice Department that alleges the hospital system engaged in a fraudulent scheme to keep patient referrals in its network.
Indianapolis-based Eli Lilly and Co. saw revenue in the third quarter increase 18 percent over the same period of 2020, to $6.77 billion.
An influential COVID-19 forecasting model is predicting increasing infections and hospitalizations in November. Also, COVID deaths per day have begun to creep back up again after a decline that started in late September.
Statewide hospitalizations due to COVID-19 have dropped 32% since the beginning of the month and 51% since hitting a recent peak of 2,687 on Sept. 13.
Indianapolis-based Langham Logistics said the facility will be dedicated to pharmaceutical, vaccine and biologics manufacturing and distribution clients.
Moderna hasn’t yet gotten the nod to offer its vaccine to teens but is studying lower doses in younger children while it waits.
Gov. Eric Holcomb is asking the state’s high court to review a judge’s ruling that upheld a new law giving legislators more power to intervene during public health emergencies.
Details of Pfizer’s study were posted online. The Food and Drug Administration was expected to post its independent review of the company’s safety and effectiveness data later in the day on Friday.
About two-thirds of Americans eligible for COVID-19 shots are fully vaccinated, and the government says getting first shots to the unvaccinated remains the priority.
Statewide hospitalizations due to COVID-19 decreased from 1,475 on Tuesday to 1,445 on Wednesday, their lowest number since Aug. 13.
Some conservative Indiana lawmakers who want to stymie planned COVID-19 vaccine mandates for private employers are facing skepticism from their own Republican leaders and the state’s largest business group.
More than 247,000 Hoosiers have already gotten vaccine boosters, after a daily increase of 5,690.
Federal regulators will meet over the next two weeks to weigh the benefits of giving shots to children, after lengthy studies meant to ensure the safety of the vaccines.